Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1895 1
1928 1
1938 1
1946 1
1947 2
1948 2
1949 2
1950 5
1951 3
1952 5
1953 8
1954 7
1955 1
1956 5
1957 3
1958 4
1959 3
1960 2
1961 1
1962 1
1963 5
1964 21
1965 58
1966 62
1967 51
1968 49
1969 64
1970 47
1971 19
1972 53
1973 47
1974 31
1975 88
1976 90
1977 100
1978 87
1979 158
1980 123
1981 72
1982 79
1983 124
1984 139
1985 124
1986 131
1987 113
1988 139
1989 139
1990 141
1991 144
1992 183
1993 223
1994 186
1995 205
1996 222
1997 219
1998 228
1999 237
2000 232
2001 242
2002 296
2003 291
2004 326
2005 327
2006 341
2007 389
2008 424
2009 443
2010 504
2011 599
2012 625
2013 709
2014 830
2015 1011
2016 1077
2017 1081
2018 1267
2019 1409
2020 1502
2021 1637
2022 176
Text availability
Article attribute
Article type
Publication date

Search Results

18,187 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Munguia-Serrano
Page 1
Biochemistry, Antinuclear Antibodies (ANA).
Nosal RS, Superville SS, Varacallo M. Nosal RS, et al. 2021 Nov 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2021 Nov 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 30725756 Free Books & Documents.
The antinuclear antibody (ANA) is a defining feature of connective tissue autoimmune disorders. ANAs are a class of antibodies that bind to cellular components in the nucleus including proteins, DNA, RNA, and nucleic acid-protein complexes. First described in 1948, ANA
The antinuclear antibody (ANA) is a defining feature of connective tissue autoimmune disorders. ANAs are a class of antibodies that b …
[Automation of the Examination for Autoantibodies].
Hayashi N. Hayashi N. Rinsho Byori. 2016 Jun;64(6):701-708. Rinsho Byori. 2016. PMID: 30695329 Review. Japanese.
Antinuclear antibody (ANA) testing is indispensable for diagnosing and estimating clinical conditions of autoimmune diseases. ...Although the computer-aided microscope system is not considered a complete system and laboratory staff should verify each result, it is a useful …
Antinuclear antibody (ANA) testing is indispensable for diagnosing and estimating clinical conditions of autoimmune diseases. ...Alth …
Distribution Characteristics of ANA and ANCA in Patients with Hyperthyroidism.
Xun C. Xun C. Endocr Metab Immune Disord Drug Targets. 2021;21(11):1993-1997. doi: 10.2174/1871530320999201111160420. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33183213
In clinical practice, we have found that ANA and ANCA often occur in sera of patients with hyperthyroidism. ...RESULTS: ANA and ANCA positive rates were higher in hyperthyroidism (33.9% and 29.2%, respectively) than those in control (4.0% and 2.0%, respectively); th …
In clinical practice, we have found that ANA and ANCA often occur in sera of patients with hyperthyroidism. ...RESULTS: ANA an …
Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis.
Choi MY, Cui J, Costenbader K, Rydzewski D, Bernhard L, Schur P. Choi MY, et al. Lupus Sci Med. 2020 Nov;7(1):e000431. doi: 10.1136/lupus-2020-000431. Lupus Sci Med. 2020. PMID: 33154098 Free PMC article. Review.
Sensitivity of HEp-2 ANA, ML ANA, repeating HEp-2 ANA, and combining HEp-2 and ML ANA assays was assessed. ...In SLE, the presence of anti-dsDNA antibodies was predictive of ANA agreement between HEp-2 and ML ANA (adjusted OR 6.27, 95% CI …
Sensitivity of HEp-2 ANA, ML ANA, repeating HEp-2 ANA, and combining HEp-2 and ML ANA assays was assessed. ...In …
ANA testing in the presence of acute and chronic infections.
Litwin CM, Binder SR. Litwin CM, et al. J Immunoassay Immunochem. 2016;37(5):439-52. doi: 10.1080/15321819.2016.1174136. J Immunoassay Immunochem. 2016. PMID: 27050929 Review.
However, a positive ANA test may also be seen with non-autoimmune inflammatory diseases, including both acute and chronic infections. ...This article identifies acute and chronic infectious diseases that are likely to produce a positive ANA result and summarizes rec …
However, a positive ANA test may also be seen with non-autoimmune inflammatory diseases, including both acute and chronic infections. …
The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia.
Birgegård G. Birgegård G. Curr Hematol Malig Rep. 2016 Oct;11(5):348-55. doi: 10.1007/s11899-016-0335-0. Curr Hematol Malig Rep. 2016. PMID: 27497846 Free PMC article. Review.
Only two randomized studies have compared the efficacy of ANA and HC in preventing thrombosis and haemorrhage, the larger of them showing a slightly better efficacy of HC, the other showing non-inferiority of ANA to HC. A recent observational 5-year study of 3600 pa …
Only two randomized studies have compared the efficacy of ANA and HC in preventing thrombosis and haemorrhage, the larger of them sho …
Anti-nuclear antibodies in patients with breast cancer.
Nisihara R, Machoski MCC, Neppel A, Maestri CA, Messias-Reason I, Skare TL. Nisihara R, et al. Clin Exp Immunol. 2018 Aug;193(2):178-182. doi: 10.1111/cei.13136. Epub 2018 Jun 14. Clin Exp Immunol. 2018. PMID: 29645079 Free PMC article.
To study the prevalence of anti-nuclear antibodies (ANA) in breast cancer patients and its association with tumour characteristics. ...Controls had ANA positivity in 54%, and when compared with tumour samples showed P < 00001. ...
To study the prevalence of anti-nuclear antibodies (ANA) in breast cancer patients and its association with tumour characteristics. . …
The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
Cha HJ, Hwang J, Lee LE, Park Y, Song JJ. Cha HJ, et al. PLoS One. 2021 Jan 7;16(1):e0244950. doi: 10.1371/journal.pone.0244950. eCollection 2021. PLoS One. 2021. PMID: 33411840 Free PMC article.

Moreover, AILD patients with the reticular ANA pattern displayed a lower positive rate for anti-smooth muscle antibodies (0% vs. 45%, p < 0.001) and nuclear ANA pattern (73.2% vs. 97.5%, p = 0.003) than those with the speckled ANA pattern. ...Thus, it is i

Moreover, AILD patients with the reticular ANA pattern displayed a lower positive rate for anti-smooth muscle antibodies (0% vs. 45%, …
Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing.
Fritzler MJ. Fritzler MJ. Autoimmun Rev. 2016 Mar;15(3):272-80. doi: 10.1016/j.autrev.2015.12.002. Epub 2015 Dec 11. Autoimmun Rev. 2016. PMID: 26687321 Review.
It is suggested that if the sole use of ANA testing is to add evidence to support a diagnosis when the pre-test probability is high, then the ANA test has limited clinical value. ...One CW recommendation that bears emphasizing is that, with a few possible exceptions …
It is suggested that if the sole use of ANA testing is to add evidence to support a diagnosis when the pre-test probability is high, …
Clinical utility of antinuclear antibody tests in children.
McGhee JL, Kickingbird LM, Jarvis JN. McGhee JL, et al. BMC Pediatr. 2004 Jul 9;4:13. doi: 10.1186/1471-2431-4-13. BMC Pediatr. 2004. PMID: 15245579 Free PMC article. Review.
The median ANA titer in children with SLE was 1: 1,080 compared with 1:160 for other children (p < 0.0001). ...ANA tests are of no diagnostic utility in either making or excluding the diagnosis of JRA....

The median ANA titer in children with SLE was 1: 1,080 compared with 1:160 for other children (p < 0.0001). ...ANA tests ar

18,187 results
You have reached the last available page of results. Please see the User Guide for more information.